Breeze Meds vs MangoRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MangoRx beats Breeze Meds overall, scoring 7.5/10 vs 7.3/10. Breeze Meds is more affordable at $199/mo vs $299/mo. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month wit. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a .

A side-by-side look at Breeze Meds and MangoRx to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Breeze Meds

#33 of 52

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Higher Rated

MangoRx

#26 of 52

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Feature	Breeze Meds	MangoRx
Our Score	7.3/10	7.5/10
Starting Price	$199/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want to order compounded GLP-1s month-by-month with no subscription commitment	Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company
Ranking	#33	#26
Get started	Visit Breeze Meds	Visit MangoRx

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required, order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
−Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
−Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.

MangoRx

Pros

+Oral dissolving tablets exclusively, zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
−Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
−Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Our Verdict

MangoRx edges out Breeze Meds with a score of 7.5/10 vs 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to MangoRx's $299/mo. Choose Breeze Meds if you want: users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose MangoRx if you want: needle-phobic users who want oral-only glp-1 tablets from a publicly traded company.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Breeze Meds nor MangoRx feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review